Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Rachael Ray is navigating grief this holiday season. She doesn't have time for 'negative energy' on the internet. - 2Brazil's agricultural research agency gets cannabis research greenlight
- 3Auschwitz Committee wants German auction of Holocaust items scrapped
- 4Best Getaway destination: Ocean side, Mountain, or City
- 5Changes to CDC website spark debate over autism and vaccine misinformation
- Doomed SpaceX Starlink satellite photographed from orbit
- Get To Be familiar with The Historical backdrop Of Western Medication
- Famous Network programs in Europe and America
- Upgrading the Healthy benefit of Your Local Vegetables
- Why Tourists May Want To Reconsider Traveling To This Popular Spot In Italy In 2026
- The Green Transformation: 5 Feasible Living Practices
- Step by step instructions to Boost the Eco-friendliness of Your Smash 1500.
- It May Take a Year to Restore Abu Dhabi Aluminum Output, EGA Says
- There are thousands of aligned holes in Peru. Archaeologists now think they know who made them
